GSK plc (BCBA:GSK)

Market Cap	101.43T
Revenue (ttm)	51.64T
Net Income (ttm)	5.59T
Shares Out	n/a
EPS (ttm)	1,348.91
PE Ratio	18.15
Forward PE	8.42
Dividend	370.37 (3.03%)
Ex-Dividend Date	May 16, 2025

Volume	151
Average Volume	3,573
Open	12,550
Previous Close	12,225
Day's Range	12,550 - 12,825
52-Week Range	9,110 - 14,400
Beta	n/a
RSI	64.30
Earnings Date	Jul 28, 2025

About GSK plc

GSK plc, together with its subsidiaries, engages in the research, development, and manufacture of vaccines, specialty medicines, and general medicines to prevent and treat disease in the United Kingdom, the United States, and internationally. It operates through Commercial Operations and Total R&D segments. The company offers specialty medicines that include oncology, respiratory/immunology, inflammation, and inhaled medicines for HIV, respiratory eosinophildriven diseases, lupus and lupus nephritis, ovarian cancer, and endometrial cancer. It a...

• Industry: Pharmaceutical Preparations
• Founded: 1715
• Employees: 68,629
• Stock Exchange: Buenos Aires Stock Exchange
• Ticker Symbol: GSK

Financial Performance

In 2024, GSK plc's revenue was 31.38 billion, an increase of 3.46% compared to the previous year's 30.33 billion. Earnings were 2.58 billion, a decrease of -47.75%.

Financial numbers in GBP